Henri Caplain

879 total citations
23 papers, 619 citations indexed

About

Henri Caplain is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Henri Caplain has authored 23 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Internal Medicine and 5 papers in Surgery. Recurrent topics in Henri Caplain's work include Atrial Fibrillation Management and Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (5 papers). Henri Caplain is often cited by papers focused on Atrial Fibrillation Management and Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (5 papers). Henri Caplain collaborates with scholars based in France, Switzerland and Canada. Henri Caplain's co-authors include J.J. Thebault, Armand Frydman, J. Bouthier, R Cariou, F. Collignon, G. Dhonneur, Y. Le Roux, Suzette Beguı́n, H.C. Hemker and Claire Bal dit Sollier and has published in prestigious journals such as The American Journal of Cardiology, European Journal of Pharmacology and British Journal of Haematology.

In The Last Decade

Henri Caplain

22 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henri Caplain France 12 287 244 206 86 81 23 619
Christian Doutremépuich France 15 222 0.8× 162 0.7× 170 0.8× 108 1.3× 37 0.5× 61 644
Federico Bertocchi Italy 18 665 2.3× 78 0.3× 136 0.7× 80 0.9× 83 1.0× 31 1.1k
J.J. Thebault France 11 211 0.7× 141 0.6× 123 0.6× 54 0.6× 56 0.7× 22 542
Giordano Cicchitelli Italy 7 527 1.8× 47 0.2× 322 1.6× 17 0.2× 69 0.9× 11 837
Gabriele Guardigli Italy 16 860 3.0× 38 0.2× 419 2.0× 34 0.4× 65 0.8× 44 1.2k
J. Bouthier France 15 446 1.6× 230 0.9× 188 0.9× 60 0.7× 61 0.8× 27 680
Lisa Dannenberg Germany 14 374 1.3× 108 0.4× 173 0.8× 55 0.6× 48 0.6× 62 678
Harry J. Crijns Netherlands 23 2.4k 8.2× 168 0.7× 133 0.6× 64 0.7× 20 0.2× 48 2.5k
Laurent Macchi France 12 438 1.5× 183 0.8× 205 1.0× 110 1.3× 15 0.2× 30 682
G Viganò Italy 12 159 0.6× 66 0.3× 151 0.7× 136 1.6× 72 0.9× 25 635

Countries citing papers authored by Henri Caplain

Since Specialization
Citations

This map shows the geographic impact of Henri Caplain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Caplain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Caplain more than expected).

Fields of papers citing papers by Henri Caplain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henri Caplain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Caplain. The network helps show where Henri Caplain may publish in the future.

Co-authorship network of co-authors of Henri Caplain

This figure shows the co-authorship network connecting the top 25 collaborators of Henri Caplain. A scholar is included among the top collaborators of Henri Caplain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henri Caplain. Henri Caplain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goyal, Vishal, Anouk Neven, Vijay Satam, et al.. (2024). Bioavailability of a novel sustained‐release pellet formulation of 5‐flucytosine in healthy‐fed participants for use in patients with cryptococcal meningitis. Clinical and Translational Science. 17(9). e13908–e13908. 1 indexed citations
2.
Goyal, Vishal, Anouk Neven, Stephen Robinson, et al.. (2024). Bioavailability of three novel oral, sustained‐release pellets, relative to an immediate‐release tablet containing 500 mg flucytosine: A randomized, open‐label, crossover study in healthy volunteers. Clinical and Translational Science. 17(3). e13756–e13756. 3 indexed citations
3.
4.
Bortel, Luc Van, Hildegard Sourgens, Kerstin Breithaupt‐Grögler, et al.. (2018). EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management. Frontiers in Pharmacology. 8. 901–901. 2 indexed citations
5.
Patat, Alain, et al.. (2010). A safety grading scale to support dose escalation and define stopping rules for healthy subject first‐entry‐into‐man studies. British Journal of Clinical Pharmacology. 70(5). 736–748. 19 indexed citations
6.
7.
Damy, Thibaud, Françoise Pousset, Henri Caplain, Jean‐Sébastien Hulot, & Philippe Lechat. (2004). Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects. Fundamental and Clinical Pharmacology. 18(1). 113–123. 47 indexed citations
8.
Sollier, Claire Bal dit, Henri Caplain, & Ludovic Drouet. (2003). No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clinical & Laboratory Haematology. 25(4). 251–253. 46 indexed citations
9.
Cambus, Jean‐Pierre, et al.. (2002). The pharmacodynamics of tinzaparin in healthy volunteers. British Journal of Haematology. 116(3). 649–652. 11 indexed citations
10.
Caplain, Henri, G. Dhonneur, & R Cariou. (1999). Prolonged heparin administration during clopidogrel treatment in healthy subjects.. PubMed. 25 Suppl 2. 61–4. 65 indexed citations
11.
Caplain, Henri, et al.. (1999). Clopidogrel does not affect the pharmacokinetics of theophylline.. PubMed. 25 Suppl 2. 65–8. 10 indexed citations
12.
Navarro, Christelle, Jean‐Pierre Cambus, Henri Caplain, et al.. (1998). Pharmacodynamics and Tolerance of Two Nadroparin Formulations (10,250 and 20,500 Anti Xa IU·ml-1) Delivered for 10 Days at Therapeutic Dose. Thrombosis and Haemostasis. 79(2). 338–341. 11 indexed citations
13.
Caplain, Henri, et al.. (1996). Inhibition of Histamine‐Induced Skin Wheal and Flare after 5 days of Mizolastine. The Journal of Clinical Pharmacology. 36(1). 72–78. 13 indexed citations
14.
Rosenzweig, P., et al.. (1995). Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.. PubMed Central. 40(5). 459–65. 34 indexed citations
15.
16.
Collignon, F., Bernadette Darné, Henri Caplain, et al.. (1992). Pharmacokinetics of enoxaparin in man given single subcutaneous doses of 1.0-1.25–1.50-2.0 mg/kg. Thrombosis Research. 65. S167–S167. 1 indexed citations
17.
Rosenzweig, P., Henri Caplain, C. Dubruc, et al.. (1992). Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine.. PubMed. 69(2). 135–9. 36 indexed citations
18.
Thiercelin, J. F., et al.. (1990). Development and Pharmacokinetics of a New Sustained-Release Formulation of Diltiazem. Journal of Cardiovascular Pharmacology. 16. S31–S37. 5 indexed citations
19.
Rosenzweig, P., J.J. Thebault, Henri Caplain, & P.L. Morselli. (1990). SL 85.0324: a new non sedative H1 antagonist drug. European Journal of Pharmacology. 183(2). 533–534. 2 indexed citations
20.
Frydman, Armand, H. W. Diekmann, René Bruno, et al.. (1989). Pharmacokinetics of nicorandil. The American Journal of Cardiology. 63(21). J25–J33. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Doutremépuich Breakdown of academic impact, for papers by Federico Bertocchi Breakdown of academic impact, for papers by J.J. Thebault Breakdown of academic impact, for papers by Giordano Cicchitelli Breakdown of academic impact, for papers by Gabriele Guardigli Breakdown of academic impact, for papers by J. Bouthier Breakdown of academic impact, for papers by Lisa Dannenberg Breakdown of academic impact, for papers by Harry J. Crijns Breakdown of academic impact, for papers by Laurent Macchi Breakdown of academic impact, for papers by G Viganò
Rankless by CCL
2026